KDR and neoplasm: Our data support the hypothesis that VEGF negatively regulates VEGFR2 expression and the tumours that produce low levels of VEGF show elevated VEGFR2 expression and decreased sensitivity to VEGFR2 kinase inhibitors (Figure 2).